Drugmakers, Interpol ramp up fight against fakes
71 days ago
The 29 companies supporting the effort include Amgen Inc., AstraZeneca PLC, Eisai Co., GlaxoSmithKline PLC, Johnson & Johnson, Eli Lilly and Co., Merck & Co., Novartis,AG, Pfizer Inc., Roche Group...
Novartis scraps $78 million noncompete deal with outgoing chairman
91 days ago
Swiss drugmaker Novartis AG has agreed with its outgoing chairman to scrap plans for a farewell noncompete deal that could have netted him up to $78 million.
Novartis scraps $78 million non-compete deal with outgoing chairman
91 days ago
Swiss drugmaker Novartis AG has agreed with its outgoing chairman to scrap plans for a farewell non-compete deal that could have netted him up to $78 million.
Novartis chairman drops $78 million parachute deal
91 days ago
Novartis chairman drops $78 million parachute deal
Alcon's exports draw federal scrutiny
118 days ago
Alcon was notified last year that the U.S. attorney's office for the Northern District of Texas is conducting an investigation into its sales, Novartis said in a regulatory filing Wednesday.
Novartis Q4 net profit rebounds to $2.1 billion
119 days ago
Novartis said Wednesday that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.
Summary Box: J&J CEO to replace retiring chairman
172 days ago
ABOUT GORSKY: He has worked for J&J since becoming a sales representative in 1988, except for a four-year stretch when he went to rival Novartis AG.
